The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to 64 years old with at least one underlying condition that could put them at risk of severe infection, the company said Saturday.
The big picture: It was the first such approval since FDA tightened COVID vaccine standards and required drugmakers to conduct more studies before approving updated shots for healthy adults under 65.
